Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression
The Journal of Pathology · 2026-12 · 270 (4) · 455-467
DOI: 10.1002/path.70115 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 19.08.2026. Verfasst von Laura Wormser und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Pancreatic Polypeptide, Protein Precursors. Die Arbeit nennt 87 Literaturangaben. Gefördert von: Interdisciplinary Center for Clinical Research Erlangen, Else Kröner-Fresenius-Stiftung, Bundesministerium für Forschung, Technologie und Raumfahrt.
Abstract (Originalsprache)
Pancreatic polypeptide (PP) and neuropeptide Y4 receptor (Y4R) are part of a conserved system that is involved in appetite regulation, gastrointestinal functions, and energy homeostasis. Experimental evidence suggests that PP–Y4R signaling might play a role in various extrahepatic cancer types, but the exact mechanisms remain unclear. Moreover, the potential role of PP–Y4R crosstalk in hepatocellular carcinoma (HCC) was unknown and has been addressed in this study. We found that the ligand (PP) and the receptor (Y4R) were markedly overexpressed in HCC cells and in patient‐derived tissues, which was correlated with a poor prognosis. Mechanistically, we found that PP promoted migration of HCC cells mediated via activation of extracellular signal‐regulated kinase (ERK) signaling. Knockdown of Y4R or pharmacological inhibition of Y4R decreased migration, clonogenicity, and proliferation of HCC cells and induced a G1‐cell cycle arrest and cellular senescence. Conversely, activation of the PP–Y4R axis was sufficient to overcome both spontaneous and sorafenib‐induced senescence, which was mediated by ERK signaling. Our study provides novel insights into the pro‐tumorigenic roles of PP and Y4R in HCC, indicating that PP–Y4R crosstalk might represent a potential novel therapeutic target. © 2026 The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
- Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
- Deutsches Zentrum für Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
- Comprehensive Cancer Center Erlangen-European Metropolitan Region Nuremberg, Erlangen, Germany.
- Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.
- European Reference Network for Rare Hepatological Diseases, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Laura Wormser, Valerie Fritz, Miriam Düll, Jonel Trebicka, Claus Hellerbrand, Anja K Bosserhoff, Peter Dietrich
Förderung
- Interdisciplinary Center for Clinical Research Erlangen
- Else Kröner-Fresenius-Stiftung
- Bundesministerium für Forschung, Technologie und Raumfahrt
- Wilhelm Sander-Stiftung
- Deutsche Krebshilfe
- Deutsche Forschungsgemeinschaft
- Bayerisches Zentrum für Krebsforschung
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Wormser, L., Kojic, S., Fritz, V., Benkert, M., Düll, M., Waldner, M., Siebler, J., Trebicka, J., Hellerbrand, C., Neurath, M. F., Bosserhoff, A. K., & Dietrich, P. (2026). Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression. The Journal of Pathology, 270(4), 455-467. https://doi.org/10.1002/path.70115
Vancouver
Wormser L, Kojic S, Fritz V, Benkert M, Düll M, Waldner M, et al. Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression. The Journal of Pathology. 2026;270(4):455-467. doi:10.1002/path.70115
BibTeX
@article{Wormser2026,
author = {Wormser, Laura and Kojic, Sabrina and Fritz, Valerie and Benkert, Matthias and Düll, Miriam and Waldner, Maximilian and Siebler, Jürgen and Trebicka, Jonel and Hellerbrand, Claus and Neurath, Markus F and Bosserhoff, Anja K and Dietrich, Peter},
title = {Pancreatic polypeptide interacts with neuropeptide Y4 receptor to promote hepatocellular carcinoma progression},
journal = {The Journal of Pathology},
year = {2026},
volume = {270},
number = {4},
pages = {455--467},
doi = {10.1002/path.70115}
}
EUVIMED